SCHEMBL24416732

SCHEMBL24416732

CCCCN(/C=C/C=C1C(=O)OC(C)(C)OC1=O)CCCC

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.40
PTPN1 P18031 3/20 0.39
ACP1 P24666 2/20 0.39
CDC25B P30305 2/20 0.39
ALDH1A1 P00352 9/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
HPGD P15428 2/20 0.35
CYP2C19 P33261 2/20 0.35
KMT2A Q03164 2/20 0.35
CRHBP P24387 2/20 0.34
CRHR2 Q13324 2/20 0.34
CYP2C9 P11712 1/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12758232 0.94 PTPN1 (0.43) APPPTPN1ACP1CDC25BALDH1A1
SCHEMBL14456205 0.90 APP (0.41) APPPTPN1ACP1CDC25BALDH1A1
SCHEMBL21128873 0.83 APP (0.43) APPPTPN1ACP1CDC25BALDH1A1
SCHEMBL12758237 0.83 APP (0.40) APPPTPN1ACP1CDC25BALDH1A1
SCHEMBL4544722 0.77 APP (0.41) APPALDH1A1HPGDKMT2AMEN1
SCHEMBL9889241 0.74 APP (0.50) APPPTPN1ALDH1A1CYP1A2CYP3A4
SCHEMBL9889238 0.73 APP (0.44) APPALDH1A1CYP1A2CYP2C19CRHBP
SCHEMBL19240037 0.72 ALDH1A1 (0.39) APPALDH1A1KMT2AMEN1POLB
SCHEMBL9892476 0.71 APP (0.37) APPALDH1A1CRHBPCRHR2L3MBTL1
SCHEMBL12758250 0.69 PTGS1 (0.35) POLBTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220144759-A1 COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-05-12 US disclosed
US-20220144769-A1 COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220144769-A1 COMPOUND CBR3, SFXN3, CBR1 APP 3557/4885PTPN1 2875/4885ACP1 3606/4885
US-20220144759-A1 COMPOUND SFXN3, SFXN1, CBR3 APP 3073/4885PTPN1 2858/4885ACP1 1780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.